These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 23204121)

  • 1. Pulmonary arterial hypertension associated with congenital heart disease.
    D'Alto M; Mahadevan VS
    Eur Respir Rev; 2012 Dec; 21(126):328-37. PubMed ID: 23204121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.
    Galie N; Manes A; Palazzini M; Negro L; Marinelli A; Gambetti S; Mariucci E; Donti A; Branzi A; Picchio FM
    Drugs; 2008; 68(8):1049-66. PubMed ID: 18484798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
    Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
    Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.
    Fine N; Dias B; Shoemaker G; Mehta S
    Can J Cardiol; 2009 Mar; 25(3):e63-8. PubMed ID: 19279988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
    Beghetti M; Galiè N
    J Am Coll Cardiol; 2009 Mar; 53(9):733-40. PubMed ID: 19245962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice: pulmonary hypertension in children.
    De Wolf D
    Eur J Pediatr; 2009 May; 168(5):515-22. PubMed ID: 19148677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
    Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
    Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.
    Diller GP; Dimopoulos K; Kaya MG; Harries C; Uebing A; Li W; Koltsida E; Gibbs JS; Gatzoulis MA
    Heart; 2007 Aug; 93(8):974-6. PubMed ID: 17639112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Kozlik-Feldmann R; Hansmann G; Bonnet D; Schranz D; Apitz C; Michel-Behnke I
    Heart; 2016 May; 102 Suppl 2():ii42-8. PubMed ID: 27053697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome.
    D'Alto M; Romeo E; Argiento P; D'Andrea A; Sarubbi B; Correra A; Scognamiglio G; Papa S; Bossone E; Calabrò R; Vizza CD; Russo MG
    Int J Cardiol; 2013 Apr; 164(3):323-6. PubMed ID: 21802156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Porto-pulmonary hypertension].
    Chabot F; Gomez E; Boyer L; Kheir A; Le Pavec J; Sitbon O; Herve P
    Rev Mal Respir; 2006 Dec; 23(6):629-41. PubMed ID: 17202968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease.
    Crepaz R; Romeo C; Montanaro D; De Santis S
    BMC Cardiovasc Disord; 2013 Sep; 13():74. PubMed ID: 24047157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies.
    D'Alto M; Diller GP
    Heart; 2014 Sep; 100(17):1322-8. PubMed ID: 24829371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
    Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
    Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease.
    Favoccia C; Constantine AH; Wort SJ; Dimopoulos K
    Expert Rev Cardiovasc Ther; 2019 Jun; 17(6):449-459. PubMed ID: 31120797
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?
    Steele P; Strange G; Wlodarczyk J; Dalton B; Stewart S; Gabbay E; Keogh A
    BMC Cardiovasc Disord; 2010 Feb; 10():9. PubMed ID: 20170553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary hypertension associated with congenital heart disease and Eisenmenger syndrome].
    Calderón-Colmenero J; Sandoval Zárate J; Beltrán Gámez M
    Arch Cardiol Mex; 2015; 85(1):32-49. PubMed ID: 25650280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
    Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.